KemPharm
Why Robinhood?
You can watch KemPharm and buy or sell other stocks, ETFs, and their options commission-free!About KMPH
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
KMPH Key Statistics
Stock Snapshot
KemPharm(KMPH) stock is priced at $8.81, giving the company a market capitalization of 500.89M. It carries a P/E multiple of 6.29.
On 2026-04-03, KemPharm(KMPH) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 731.55K.
The stock's 52-week range extends from a low of $6.19 to a high of $13.16.
The stock's 52-week range extends from a low of $6.19 to a high of $13.16.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.